SCHEMBL3042274

SCHEMBL3042274

O=Cc1c2ccccc2nc2ccccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 4/20 0.61
KDM4E B2RXH2 6/20 0.50
ALDH1A1 P00352 5/20 0.50
GLA P06280 4/20 0.50
HPGD P15428 3/20 0.50
MAOA P21397 2/20 0.50
CASP1 P29466 2/20 0.50
CASP7 P55210 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
HSD17B10 Q99714 2/20 0.50
CHRM2 P08172 1/20 0.50
ADRA2A P08913 1/20 0.50
ADORA3 P0DMS8 1/20 0.50
CHRM1 P11229 1/20 0.50
NQO2 P16083 1/20 0.50
DRD1 P21728 1/20 0.50
ACHE P22303 1/20 0.50
SLC6A2 P23975 1/20 0.50
ADRA1A P35348 1/20 0.50
OPRM1 P35372 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrazine SCHEMBL28066974 0.96 ERN1 (0.58) ERN1KDM4EALDH1A1GLAHPGD
SCHEMBL5852389 0.84 ERN1 (0.55) ERN1KDM4EALDH1A1MAOAHSD17B10
SCHEMBL6646525 0.81 ERN1 (0.49) ERN1ALDH1A1MAOASMN1; SMN2HSD17B10
Benzene SCHEMBL27502416 0.80 ERN1 (0.51) ERN1KDM4EALDH1A1MAOASMN1; SMN2
SCHEMBL20659678 0.80 ERN1 (0.70) ERN1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL9364466 0.80 ERN1 (0.51) ERN1KDM4EALDH1A1GLAHPGD
SCHEMBL11873676 0.80 ERN1 (0.48) ERN1ALDH1A1CASP1CASP7SMN1; SMN2
SCHEMBL13271201 0.80 ERN1 (0.55) ERN1KDM4EALDH1A1HPGDRAB9A
SCHEMBL13313363 0.80 CYP1A2 (0.58) ERN1KDM4EALDH1A1HPGDNQO2
SCHEMBL986883 0.79 PADI4 (0.64) ERN1KDM4EALDH1A1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070123469-A1 N- or C- terminally modified small peptides ZEALAND PHARMA A/S (DK) 2007-05-31 US claimed
EP-1433785-A1 Agents for the coloration of keratinous fibres Henkel Kommanditgesellschaft auf Aktien (DE) 2004-06-30 EP claimed
WO-2004024058-A2 MOLECULES WITH ANTITUMOR ACTIVITY AND CHEMICAL SYNTHESIS CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ (BR) 2004-03-25 WO claimed
WO-1997027179-A2 ANTIRETROVIRAL BASES NOVARTIS AG (CH) 1997-07-31 WO claimed
US-20250237947-A1 Dry Film Resist, Photosensitive Dry Film, and Copper Clad Laminate HANGZHOU FIRST ELECTRONIC MATERIAL CO., LTD (CN) 2025-07-24 US disclosed
CN-118871861-A Dry film resist, photosensitive dry film and copper-clad plate 杭州福斯特电子材料有限公司 2024-10-29 CN disclosed
WO-2023185530-A1 DRY FILM RESIST, PHOTOSENSITIVE DRY FILM, AND COPPER CLAD LAMINATE 杭州福斯特电子材料有限公司 2023-10-05 WO disclosed
US-20230242585-A1 IMMUNOMODULATORS BRISTOL MYERS SQUIBB CO (US) 2023-08-03 US disclosed
US-20230242585-A1 IMMUNOMODULATORS BRISTOL MYERS SQUIBB CO (US) 2023-08-03 US disclosed
CN-114660895-A Dry film resist, photosensitive dry film and copper-clad plate 杭州福斯特电子材料有限公司 2022-06-24 CN disclosed
CN-114276352-A Carbon-11 labeled Larotrectinib compound and preparation method thereof 上海健康医学院 2022-04-05 CN disclosed
WO-2021226460-A1 IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2021-11-11 WO disclosed
WO-1997027179-A2 ANTIRETROVIRAL BASES NOVARTIS AG (CH) 1997-07-31 WO disclosed
US-5225584-A Phosphonate esters and trialkylsilyl phosphonate esters TROPIX, INC. (US) 1993-07-06 US disclosed
EP-0041675-B1 4-HALOGEN-5-(TRICHLOROMETHYL-PHENYL)-OXAZOLE DERIVATIVES, PROCESS FOR PREPARING THEM AND RADIATION-SENSITIVE COMPOSITIONS CONTAINING THEM HOECHST AKTIENGESELLSCHAFT (DE) 1985-12-11 EP disclosed
US-4371607-A 4-Halogeno-5-(halogenomethyl-phenyl)-oxazole derivatives, a process for the preparation thereof, and radiation-sensitive compositions containing these derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1983-02-01 US disclosed
US-4344956-A Oxotetrahydrothiophenes ERCOLI NICOLO 1982-08-17 US disclosed
EP-0041675-A2 4-Halogen-5-(trichloromethyl-phenyl)-oxazole derivatives, process for preparing them and radiation-sensitive compositions containing them HOECHST AKTIENGESELLSCHAFT (DE) 1981-12-16 EP disclosed
US-4017313-A Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-04-12 US disclosed
US-3994688-A REACTING L-LYSINE WITH A G-FORMYL-PYRIDINE DERIVATIVE A/S N. FOSS ELECTRIC (DK) 1976-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242585-A1 IMMUNOMODULATORS CD274, PDCD1, PDCD1LG2 ERN1 2721/4885KDM4E 2092/4885ALDH1A1 3370/4885
US-20250237947-A1 Dry Film Resist, Photosensitive Dry Film, and Copper Clad Laminate PADI2, PADI4, PADI1 ERN1 2640/4885KDM4E 529/4885ALDH1A1 944/4885
US-20070123469-A1 N- or C- terminally modified small peptides PTMS, CYP11A1, CYP3A4 ERN1 2336/4885KDM4E 2661/4885ALDH1A1 1790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.